{{Rsnum
|rsid=32934
|Gene=F2R
|Chromosome=5
|position=76714881
|Orientation=plus
|GMAF=0.1524
|Gene_s=F2R
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 86.7 | 11.5 | 1.8
| HCB | 35.1 | 47.0 | 17.9
| JPT | 37.2 | 49.6 | 13.3
| YRI | 85.5 | 13.8 | 0.7
| ASW | 86.0 | 14.0 | 0.0
| CHB | 35.1 | 47.0 | 17.9
| CHD | 39.4 | 46.8 | 13.8
| GIH | 92.1 | 7.9 | 0.0
| LWK | 91.8 | 8.2 | 0.0
| MEX | 79.3 | 20.7 | 0.0
| MKK | 95.5 | 3.8 | 0.6
| TSI | 89.1 | 10.9 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=23517743
|Title=The protease activated receptor 1 gene variation IVSn -14A&gt;T is associated with distant metastasis and cancer-specific survival in renal cell carcinoma
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA}}
{{on chip | Illumina Human 1M}}